These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12095042)

  • 1. Effect of extended coverage of immunosuppressive medications by medicare on the survival of cadaveric renal transplants.
    Woodward RS; Schnitzler MA; Lowell JA; Spitznagel EL; Brennan DC
    Am J Transplant; 2001 May; 1(1):69-73. PubMed ID: 12095042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Income-related disparities in kidney transplant graft failures are eliminated by Medicare's immunosuppression coverage.
    Woodward RS; Page TF; Soares R; Schnitzler MA; Lentine KL; Brennan DC
    Am J Transplant; 2008 Dec; 8(12):2636-46. PubMed ID: 19032227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant.
    Yen EF; Hardinger K; Brennan DC; Woodward RS; Desai NM; Crippin JS; Gage BF; Schnitzler MA
    Am J Transplant; 2004 Oct; 4(10):1703-8. PubMed ID: 15367228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of Medicare's coverage of immunosuppression medications for kidney transplant recipients.
    Page TF; Woodward RS
    Expert Rev Pharmacoecon Outcomes Res; 2009 Oct; 9(5):435-44. PubMed ID: 19817527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1996; ():1-14. PubMed ID: 9286555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic cost of expanded criteria donors in cadaveric renal transplantation: analysis of Medicare payments.
    Whiting JF; Woodward RS; Zavala EY; Cohen DS; Martin JE; Singer GG; Lowell JA; First MR; Brennan DC; Schnitzler MA
    Transplantation; 2000 Sep; 70(5):755-60. PubMed ID: 11003352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of lifetime immunosuppression coverage for kidney transplant recipients.
    Page TF; Woodward RS
    Health Care Financ Rev; 2008; 30(2):95-104. PubMed ID: 19361119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Medicare's lifetime immunosuppression coverage on racial disparities in kidney graft survival.
    Page TF; Woodward RS; Brennan DC
    Am J Transplant; 2012 Jun; 12(6):1519-27. PubMed ID: 22335186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A; Woo KT
    Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The UNOS scientific renal transplant registry. United Network for Organ Sharing.
    Cecka JM; Terasaki PI
    Clin Transpl; 1995; ():1-18. PubMed ID: 8794251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic Evaluation of Extending Medicare Immunosuppressive Drug Coverage for Kidney Transplant Recipients in the Current Era.
    Kadatz M; Gill JS; Gill J; Formica RN; Klarenbach S
    J Am Soc Nephrol; 2020 Jan; 31(1):218-228. PubMed ID: 31704739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney transplantation, the Halifax experience.
    Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
    Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic impact and long-term graft outcomes of mycophenolate mofetil dosage modifications following gastrointestinal complications in renal transplant recipients.
    Machnicki G; Ricci JF; Brennan DC; Schnitzler MA
    Pharmacoeconomics; 2008; 26(11):951-67. PubMed ID: 18850764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Center effects in renal transplantation.
    Ogura K; Cecka JM
    Clin Transpl; 1991; ():245-56. PubMed ID: 1820120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The OPTN/UNOS Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 2005; ():1-16. PubMed ID: 17424721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The UNOS Scientific Renal Transplant Registry. United Network for Organ Sharing.
    Cecka JM; Terasaki PI
    Clin Transpl; 1994; ():1-18. PubMed ID: 7547529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen.
    Irish W; Sherrill B; Brennan DC; Lowell J; Schnitzler M
    Transplantation; 2003 Dec; 76(12):1686-90. PubMed ID: 14688516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.